Analyst Ratings-USA
Ratings Outlook Summary
Today’s analyst updates reveal a broadly bullish sentiment across sectors, with the majority of ratings being “Buy” and several upward price target revisions. Notable momentum is seen in healthcare and biotech (e.g., ACADIA, Sarepta, Harmony Biosciences, Capricor) and technology (AMD, Meta, Equinix, Accenture), where analysts highlight strong fundamentals, strategic positioning, and upside from innovation.
Despite many upgrades, some names (e.g., AST SpaceMobile, JPMorgan, Citigroup, General Mills) were held or downgraded, indicating valuation concerns or macroeconomic pressures. Overall, analysts are positioning for continued growth but with selective caution, especially in sectors like financials and industrials, where price targets are more tempered. The broad coverage update shows that institutional outlook remains confident in U.S. equities, particularly those with strong earnings visibility, innovation edge, or defensiveness in current economic conditions.
Analyst Ratings:
Company Name |
Symbol |
Action |
Investment Bank Name |
Analyst Rating |
Price |
|
ACADIA Pharmaceuticals |
ACAD |
Target Up |
RBC Capital |
Buy |
$38.00 |
|
Accenture |
ACN |
Target Update |
TD Cowen |
Buy |
$342.00 |
|
Accenture |
ACN |
Target Update |
Susquehanna |
Hold |
$330.00 |
|
Accenture |
ACN |
Target Update |
Stifel Nicolaus |
Buy |
$355.00 |
|
ACI Worldwide |
ACIW |
Target Update |
D.A. Davidson |
Buy |
$60.00 |
|
Adobe |
ADBE |
Maintains |
JMP Securities |
Market Perform |
$378.00 |
|
Advanced Micro Devices |
AMD |
Upgrades |
Melius Research |
Buy |
$175.00 |
|
AGNC Investment |
AGNC |
Target Update |
Piper Sandler |
Buy |
$10.00 |
|
Alcoa |
AA |
Target Update |
Morgan Stanley |
Buy |
$37.50 |
|
Alkermes |
ALKS |
Target Update |
Stifel Nicolaus |
Buy |
$42.00 |
|
Ally Financial |
ALLY |
Target Update |
Citi |
Buy |
$55.00 |
|
Alpha Teknova |
TKNO |
Target Update |
TD Cowen |
Buy |
$10.00 |
|
AMMO |
POWW |
Target Update |
Lake Street |
Buy |
$2.00 |
|
Array Technologies |
ARRY |
Target Update |
Morgan Stanley |
Hold |
$6.00 |
|
AST SpaceMobile |
ASTS |
Downgrades |
Scotiabank |
Sector Perform |
$45.00 |
|
Bank of America |
BAC |
Target Update |
Morgan Stanley |
Buy |
$49.00 |
|
Bankwell Financial Group |
BWFG |
Target Update |
Hovde Group |
Hold |
$38.50 |
|
BlackBerry Ltd. |
BB |
Target Update |
RBC Capital |
Sector Perform |
$3.75 |
|
BlackRock |
BLK |
Target Update |
TD Cowen |
Buy |
$1,154.00 |
|
California Resources Corp |
CRC |
Target Update |
Roth MKM |
Buy |
$48.00 |
|
Canadian Pacific Kansas City |
TSE:CP |
Target Update |
Bernstein |
Hold |
$115.00 |
|
Capricor Therapeutics |
CAPR |
Target Update |
Oppenheimer |
Buy |
$22.00 |
|
CarMax |
KMX |
Target Update |
Mizuho Securities |
Hold |
$80.00 |
|
Caterpillar |
CAT |
Target Update |
Truist Financial |
Buy |
$414.00 |
|
Centrus Energy |
LEU |
Target Update |
B.Riley Financial |
Buy |
$221.00 |
|
CERo Therapeutics Holdings |
CERO |
Target Update |
D. Boral Capital |
Buy |
$30.00 |
|
Citigroup |
C |
Target Update |
Morgan Stanley |
Buy |
$94.00 |
|
Codexis |
CDXS |
Target Update |
TD Cowen |
Hold |
$3.00 |
|
COMPASS Pathways |
CMPS |
Target Update |
Evercore ISI |
Hold |
$6.00 |
|
Corporacion Inmobiliaria Vesta |
VTMX |
Target Update |
Barclays |
Buy |
$37.00 |
|
Coterra Energy |
CTRA |
Target Update |
Wells Fargo |
Buy |
$31.00 |
|
Cytek Biosciences |
CTKB |
Target Update |
TD Cowen |
Hold |
$4.00 |
|
Darden Restaurants |
DRI |
Target Update |
Evercore ISI |
Buy |
$250.00 |
|
Darden Restaurants |
DRI |
Target Update |
Raymond James |
Buy |
$240.00 |
|
Darden Restaurants |
DRI |
Target Update |
Oppenheimer |
Buy |
$250.00 |
|
Darden Restaurants |
DRI |
Target Update |
Truist Financial |
Buy |
$252.00 |
|
Dianthus Therapeutics |
DNTH |
Target Update |
Stifel Nicolaus |
Buy |
$52.00 |
|
Eli Lilly & Co |
LLY |
Target Update |
Bernstein |
Buy |
$1,100.00 |
|
EOG Resources |
EOG |
Target Update |
Wells Fargo |
Buy |
$149.00 |
|
Equinix |
EQIX |
Target Update |
Citi |
Buy |
$990.00 |
|
Equinix |
EQIX |
Target Update |
TD Cowen |
Buy |
$1,018.00 |
|
Evolent Health |
EVH |
Target Update |
UBS |
Buy |
$15.00 |
|
Exelixis |
EXEL |
Target Update |
Truist Financial |
Buy |
$55.00 |
|
First Interstate Bancsystem |
FIBK |
Target Update |
KBW |
Buy |
$32.00 |
|
Flywire |
FLYW |
Target Update |
B.Riley Financial |
Buy |
$15.00 |
|
General Mills |
GIS |
Target Update |
RBC Capital |
Hold |
$67.00 |
|
Goldman Sachs Group |
GS |
Target Update |
Morgan Stanley |
Hold |
$592.00 |
|
Guild Holdings |
GHLD |
Target Update |
BTIG |
Buy |
$18.00 |
|
GXO Logistics |
GXO |
Target Update |
Morgan Stanley |
Buy |
$56.00 |
|
Harmony Biosciences Holdings |
HRMY |
Target Update |
Mizuho Securities |
Buy |
$48.00 |
|
HCA Healthcare |
HCA |
Target Update |
RBC Capital |
Buy |
$404.00 |
|
Home Depot |
HD |
Target Update |
TD Cowen |
Buy |
$470.00 |
|
Illumina |
ILMN |
Target Update |
Piper Sandler |
Buy |
$185.00 |
|
Janus Henderson Group |
JHG |
Target Update |
Wells Fargo |
Hold |
$37.00 |
|
JPMorgan Chase |
JPM |
Target Update |
Morgan Stanley |
Hold |
$240.00 |
|
Kroger Company |
KR |
Target Update |
Wells Fargo |
Buy |
$78.00 |
|
Kroger Company |
KR |
Target Update |
Bank of America Securities |
Buy |
$75.00 |
|
Lantheus |
LNTH |
Target Update |
B.Riley Financial |
Buy |
$109.00 |
|
Lineage Therap |
LCTX |
Target Update |
Craig-Hallum |
Buy |
$3.00 |
|
Mach Natural Resources LP |
MNR |
Target Update |
Raymond James |
Buy |
$21.00 |
|
Meta Platforms |
META |
Target Update |
Monness |
Buy |
$780.00 |
|
Myomo |
MYO |
Target Update |
Craig-Hallum |
Buy |
$8.00 |
|
Ocular Therapeutix |
OCUL |
Target Update |
Piper Sandler |
Buy |
$21.00 |
|
Olo |
OLO |
Target Update |
Truist Financial |
Buy |
$10.50 |
|
OmniAb |
OABI |
Target Update |
TD Cowen |
Buy |
$4.00 |
|
Orthofix |
OFIX |
Target Update |
Barrington |
Buy |
$16.00 |
|
Perspective Therapeutics |
CATX |
Target Update |
LifeSci Capital |
Buy |
$17.00 |
|
Perspective Therapeutics |
CATX |
Target Update |
B.Riley Financial |
Buy |
$12.00 |
|
Perspective Therapeutics |
CATX |
Target Update |
Oppenheimer |
Buy |
$15.00 |
|
Perspective Therapeutics |
CATX |
Target Update |
Scotiabank |
Buy |
$15.00 |
|
PPG Industries |
PPG |
Target Update |
Mizuho Securities |
Buy |
$125.00 |
|
Prenetics Group |
PRE |
Target Update |
Cantor Fitzgerald |
Buy |
$14.00 |
|
Pursuit Attractions and Hospitality |
PRSU |
Target Update |
Oppenheimer |
Buy |
$41.00 |
|
Roblox |
RBLX |
Target Update |
Oppenheimer |
Buy |
$125.00 |
|
SAGE Therapeutics |
SAGE |
Target Update |
J.P. Morgan |
Hold |
$8.50 |
|
Sarepta Therapeutics |
SRPT |
Target Update |
J.P. Morgan |
Buy |
$30.00 |
|
Sarepta Therapeutics |
SRPT |
Target Update |
TD Cowen |
Hold |
$24.00 |
|
Sarepta Therapeutics |
SRPT |
Target Update |
Piper Sandler |
Hold |
$36.00 |
|
Shift4 Payments |
FOUR |
Target Update |
D.A. Davidson |
Buy |
$124.00 |
|
Smith & Wesson Brands |
SWBI |
Target Update |
Lake Street |
Buy |
$11.00 |
|
Solid Biosciences |
SLDB |
Target Update |
Piper Sandler |
Buy |
$17.00 |
|
Starbucks |
SBUX |
Target Update |
Piper Sandler |
Buy |
$102.00 |
|
Structure Therapeutics, Inc. Sponsored ADR |
GPCR |
Target Update |
Citizens JMP |
Buy |
$89.00 |
|
Sturm Ruger & Company |
RGR |
Target Update |
Lake Street |
Buy |
$41.00 |
|
Target Corp |
TGT |
Target Update |
Barclays |
Hold |
$91.00 |
|
Tenaris SA |
TS |
Target Update |
TD Cowen |
Buy |
$43.00 |
|
Tesla |
TSLA |
Target Update |
TD Cowen |
Buy |
$330.00 |
|
TuHURA Biosciences |
HURA |
Target Update |
Brookline Capital Markets |
Buy |
$9.00 |
|
Upstart Holdings |
UPST |
Target Update |
Bank of America Securities |
Hold |
$59.00 |
|
Ventas |
VTR |
Target Update |
Scotiabank |
Hold |
$72.00 |
|
Vertex Pharmaceuticals |
VRTX |
Target Update |
Scotiabank |
Hold |
$442.00 |
|
Vicor |
VICR |
Target Update |
Craig-Hallum |
Hold |
$50.00 |
|
Wabash National |
WNC |
Target Update |
D.A. Davidson |
Hold |
$9.50 |
|
Welltower |
WELL |
Target Update |
Scotiabank |
Hold |
$172.00 |
|
XP |
XP |
Target Update |
Itau Unibanco |
Hold |
$21.00 |
|
STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.
The selective caution in sectors like financials and industrials makes a lot of sense. With macroeconomic pressures continuing, it’s smart for analysts to temper expectations in these areas while focusing on the innovation-driven sectors. It’ll be interesting to see how these trends unfold in the second half of the year.